• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

糖尿病导致心力衰竭和心力衰竭导致糖尿病:流行病学和临床证据。

Diabetes leading to heart failure and heart failure leading to diabetes: epidemiological and clinical evidence.

机构信息

Cardiovascular Diseases Unit, Cardio-Thoracic and Vascular Department, S. Maria Alle Scotte Hospital, University of Siena, Siena, Italy.

Department of Medical and Surgical Sciences, University of Foggia, Via Luigi Pinto 1, 71121, Foggia, Italy.

出版信息

Heart Fail Rev. 2023 May;28(3):585-596. doi: 10.1007/s10741-022-10238-6. Epub 2022 May 6.

DOI:10.1007/s10741-022-10238-6
PMID:35522391
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC10140137/
Abstract

Type 2 diabetes mellitus (T2DM) is a risk factor that plays a major role in the onset of heart failure (HF) both directly, by impairing cardiac function, and indirectly, through associated diseases such as hypertension, coronary disease, renal dysfunction, obesity, and other metabolic disorders. In a population of HF patients, the presence of T2DM ranged from 20 to 40%, according to the population studied, risk factor characteristics, geographic area, and age, and it is associated with a worse prognosis. Finally, patients with HF, when compared with those without HF, show an increased risk for the onset of T2DM due to several mechanisms that predispose the HF patient to insulin resistance. Despite the epidemiological data confirmed the relationship between T2DM and HF, the exact prevalence of HF in T2DM comes from interventional trials rather than from observational registries aimed to prospectively evaluate the risk of HF occurrence in T2DM population. This review is focused on the vicious cycle linking HF and T2DM, from epidemiological data to prognostic implications.

摘要

2 型糖尿病(T2DM)是心力衰竭(HF)发病的主要危险因素,它通过损害心脏功能直接作用,也通过高血压、冠心病、肾功能障碍、肥胖和其他代谢紊乱等相关疾病间接作用。根据研究人群、危险因素特征、地理区域和年龄的不同,在 HF 患者人群中,T2DM 的患病率在 20%到 40%之间,并且与预后较差相关。最后,与无 HF 的患者相比,HF 患者由于多种导致 HF 患者发生胰岛素抵抗的机制,发生 T2DM 的风险增加。尽管流行病学数据证实了 T2DM 与 HF 之间的关系,但 T2DM 中 HF 的确切患病率来自于干预性试验,而不是旨在前瞻性评估 T2DM 人群 HF 发生风险的观察性登记研究。本综述重点关注将 HF 和 T2DM 联系起来的恶性循环,从流行病学数据到预后意义。

https://cdn.ncbi.nlm.nih.gov/pmc/blobs/7b3f/10140137/c8db97d231c0/10741_2022_10238_Fig2_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/7b3f/10140137/b76cb7255f74/10741_2022_10238_Fig1_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/7b3f/10140137/c8db97d231c0/10741_2022_10238_Fig2_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/7b3f/10140137/b76cb7255f74/10741_2022_10238_Fig1_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/7b3f/10140137/c8db97d231c0/10741_2022_10238_Fig2_HTML.jpg

相似文献

1
Diabetes leading to heart failure and heart failure leading to diabetes: epidemiological and clinical evidence.糖尿病导致心力衰竭和心力衰竭导致糖尿病:流行病学和临床证据。
Heart Fail Rev. 2023 May;28(3):585-596. doi: 10.1007/s10741-022-10238-6. Epub 2022 May 6.
2
Type 2 diabetes increases the long-term risk of heart failure and mortality in patients with atrial fibrillation.2 型糖尿病增加了伴有心房颤动患者心力衰竭和死亡的长期风险。
Eur J Heart Fail. 2020 Jan;22(1):113-125. doi: 10.1002/ejhf.1666. Epub 2019 Dec 10.
3
Prognostic Implications of Type 2 Diabetes Mellitus in Ischemic and Nonischemic Heart Failure.2 型糖尿病与缺血性和非缺血性心力衰竭的预后意义。
J Am Coll Cardiol. 2016 Sep 27;68(13):1404-1416. doi: 10.1016/j.jacc.2016.06.061.
4
Type 2 diabetes mellitus and heart failure: a position statement from the Heart Failure Association of the European Society of Cardiology.2 型糖尿病与心力衰竭:欧洲心脏病学会心力衰竭协会立场声明。
Eur J Heart Fail. 2018 May;20(5):853-872. doi: 10.1002/ejhf.1170. Epub 2018 Mar 8.
5
Potential Effects of Bariatric Surgery on the Incidence of Heart Failure and Atrial Fibrillation in Patients With Type 2 Diabetes Mellitus and Obesity and on Mortality in Patients With Preexisting Heart Failure: A Nationwide, Matched, Observational Cohort Study.肥胖症合并 2 型糖尿病患者行减重手术对心力衰竭和心房颤动发生率及对合并心力衰竭患者死亡率的潜在影响:一项全国范围内匹配的观察性队列研究。
J Am Heart Assoc. 2021 Apr 6;10(7):e019323. doi: 10.1161/JAHA.120.019323. Epub 2021 Mar 23.
6
Prognostic Value of Secreted Frizzled-Related Protein 5 in Heart Failure Patients With and Without Type 2 Diabetes Mellitus.分泌型卷曲相关蛋白 5 在合并和不合并 2 型糖尿病的心力衰竭患者中的预后价值。
Circ Heart Fail. 2020 Sep;13(9):e007054. doi: 10.1161/CIRCHEARTFAILURE.120.007054. Epub 2020 Aug 26.
7
What's new in heart failure in the patient with type 2 diabetes?2型糖尿病患者心力衰竭有哪些新进展?
Endocrinol Nutr. 2015 Aug-Sep;62(7):350-5. doi: 10.1016/j.endonu.2015.06.004. Epub 2015 Jul 27.
8
Prevalence of cardiac abnormalities and heart failure in unselected out-patients with type 2 diabetes mellitus and associated clinical factors: Real-world evidence from an Indian registry.在未选择的 2 型糖尿病门诊患者中心脏异常和心力衰竭的流行情况及其相关临床因素:来自印度注册登记的真实世界证据。
Indian Heart J. 2023 Nov-Dec;75(6):436-442. doi: 10.1016/j.ihj.2023.10.003. Epub 2023 Oct 24.
9
Prediction of heart failure in patients with type 2 diabetes mellitus- a systematic review and meta-analysis.2型糖尿病患者心力衰竭的预测——一项系统评价和荟萃分析。
Diabetes Res Clin Pract. 2015 Apr;108(1):55-66. doi: 10.1016/j.diabres.2015.01.011. Epub 2015 Jan 20.
10
The heart failure burden of type 2 diabetes mellitus-a review of pathophysiology and interventions.2 型糖尿病的心力衰竭负担——病理生理学和干预措施的综述。
Heart Fail Rev. 2018 May;23(3):303-323. doi: 10.1007/s10741-018-9685-0.

引用本文的文献

1
Can Gene Expression Differentiate Patients With Heart Failure due to Coronary Heart Disease From Patients With Coronary Disease Without Heart Failure?基因表达能否区分冠心病所致心力衰竭患者与无心力衰竭的冠心病患者?
J Cell Mol Med. 2025 Sep;29(17):e70727. doi: 10.1111/jcmm.70727.
2
Developing a risk score for B-type natriuretic peptide (BNP) ≥ 100 pg/ml levels: the suita study.开发用于B型利钠肽(BNP)≥100 pg/ml水平的风险评分:须田研究
BMC Cardiovasc Disord. 2025 Sep 2;25(1):649. doi: 10.1186/s12872-025-05031-w.
3
Impact of Gliflozins on Right Heart Remodeling in Italian Patients with Type 2 Diabetes and Heart Failure: Results from the GLISCAR Real-World Study.

本文引用的文献

1
Empagliflozin in Heart Failure with a Preserved Ejection Fraction.恩格列净治疗射血分数保留的心力衰竭。
N Engl J Med. 2021 Oct 14;385(16):1451-1461. doi: 10.1056/NEJMoa2107038. Epub 2021 Aug 27.
2
2021 ESC Guidelines for the diagnosis and treatment of acute and chronic heart failure.2021年欧洲心脏病学会急性和慢性心力衰竭诊断与治疗指南。
Eur Heart J. 2021 Sep 21;42(36):3599-3726. doi: 10.1093/eurheartj/ehab368.
3
Cardiovascular Biomarkers and Heart Failure Risk in Stable Patients With Atherothrombotic Disease: A Nested Biomarker Study From TRA 2°P-TIMI 50.
格列净类药物对意大利2型糖尿病合并心力衰竭患者右心重构的影响:GLISCAR真实世界研究结果
Pharmaceuticals (Basel). 2025 Aug 14;18(8):1200. doi: 10.3390/ph18081200.
4
Molecular Insights into the Potential Cardiometabolic Effects of GLP-1 Receptor Analogs and DPP-4 Inhibitors.胰高血糖素样肽-1受体类似物和二肽基肽酶-4抑制剂潜在心脏代谢效应的分子见解
Int J Mol Sci. 2025 Jul 15;26(14):6777. doi: 10.3390/ijms26146777.
5
The effect of empagliflozin on cardiac function and structure in patients with heart failure with reduced ejection fraction: a systematic review and meta-analysis.恩格列净对射血分数降低的心力衰竭患者心脏功能和结构的影响:一项系统评价和荟萃分析。
Postepy Kardiol Interwencyjnej. 2025 May 27;21(2):146-154. doi: 10.5114/aic.2025.151600. eCollection 2025 Jun.
6
Sarcoplasmic reticulum-mitochondria microdomains: hugging and kissing in the heart.肌浆网-线粒体微区:心脏中的“相拥”与“亲吻”
Am J Physiol Cell Physiol. 2025 Aug 1;329(2):C599-C610. doi: 10.1152/ajpcell.00435.2025. Epub 2025 Jul 11.
7
Superior cardiovascular protection with GLP-1 RAs over SGLT2 inhibitors in DM and HFpEF: A propensity score matching study.在糖尿病和射血分数保留的心力衰竭患者中,胰高血糖素样肽-1受体激动剂比钠-葡萄糖协同转运蛋白2抑制剂具有更好的心血管保护作用:一项倾向评分匹配研究。
PLoS One. 2025 Jun 26;20(6):e0326534. doi: 10.1371/journal.pone.0326534. eCollection 2025.
8
Impact of diabetes and ejection fraction on non-ST-Segment elevation myocardial infarction outcomes.糖尿病和射血分数对非ST段抬高型心肌梗死预后的影响。
Heart Vessels. 2025 Jun 23. doi: 10.1007/s00380-025-02564-0.
9
Tirzepatide, a dual GIP/GLP1-receptor co-agonist preserves cardiac function and improves survival in angiotensin II-induced heart failure model in mice: comparison to liraglutide.替尔泊肽,一种双重GIP/GLP-1受体激动剂,可维持小鼠血管紧张素II诱导的心力衰竭模型中的心脏功能并提高生存率:与利拉鲁肽的比较。
Cardiovasc Diabetol. 2025 Jun 14;24(1):253. doi: 10.1186/s12933-025-02806-5.
10
Translational disease modeling of peripheral blood identifies type 2 diabetes biomarkers predictive of Alzheimer's disease.外周血的转化疾病模型确定了预测阿尔茨海默病的2型糖尿病生物标志物。
NPJ Syst Biol Appl. 2025 May 29;11(1):58. doi: 10.1038/s41540-025-00539-5.
动脉粥样硬化血栓形成疾病稳定患者的心血管生物标志物与心力衰竭风险:TRA 2°P-TIMI 50 的嵌套生物标志物研究。
J Am Heart Assoc. 2021 May 4;10(9):e018673. doi: 10.1161/JAHA.120.018673. Epub 2021 Apr 22.
4
Dapagliflozin and Recurrent Heart Failure Hospitalizations in Heart Failure With Reduced Ejection Fraction: An Analysis of DAPA-HF.达格列净与射血分数降低的心力衰竭患者心力衰竭再住院:DAPA-HF 分析。
Circulation. 2021 May 18;143(20):1962-1972. doi: 10.1161/CIRCULATIONAHA.121.053659. Epub 2021 Apr 9.
5
Heart failure hospitalisation relative to major atherosclerotic events in type 2 diabetes with versus without chronic kidney disease: A meta-analysis of cardiovascular outcomes trials.心力衰竭住院与 2 型糖尿病伴或不伴慢性肾脏病患者主要动脉粥样硬化事件的关系:心血管结局试验的荟萃分析。
Diabetes Metab. 2021 Sep;47(5):101249. doi: 10.1016/j.diabet.2021.101249. Epub 2021 Mar 17.
6
Universal definition and classification of heart failure: a report of the Heart Failure Society of America, Heart Failure Association of the European Society of Cardiology, Japanese Heart Failure Society and Writing Committee of the Universal Definition of Heart Failure: Endorsed by the Canadian Heart Failure Society, Heart Failure Association of India, Cardiac Society of Australia and New Zealand, and Chinese Heart Failure Association.心力衰竭的通用定义和分类:美国心力衰竭学会、欧洲心脏病学会心力衰竭协会、日本心力衰竭学会和心力衰竭通用定义写作委员会的报告:得到加拿大心力衰竭学会、印度心力衰竭协会、澳大利亚和新西兰心脏病学会以及中国心力衰竭协会的认可。
Eur J Heart Fail. 2021 Mar;23(3):352-380. doi: 10.1002/ejhf.2115. Epub 2021 Mar 3.
7
Impact of diabetes on serum biomarkers in heart failure with preserved ejection fraction: insights from the TOPCAT trial.糖尿病对射血分数保留的心力衰竭患者血清生物标志物的影响:TOPCAT试验的见解
ESC Heart Fail. 2021 Apr;8(2):1130-1138. doi: 10.1002/ehf2.13153. Epub 2021 Jan 12.
8
How Diabetes and Heart Failure Modulate Each Other and Condition Management.糖尿病与心力衰竭的相互作用及综合管理。
Can J Cardiol. 2021 Apr;37(4):595-608. doi: 10.1016/j.cjca.2020.11.014. Epub 2020 Dec 1.
9
Relationship between baseline cardiac biomarkers and cardiovascular death or hospitalization for heart failure with and without sodium-glucose co-transporter 2 inhibitor therapy in DECLARE-TIMI 58.DECLARE-TIMI 58 研究中基线心脏生物标志物与钠-葡萄糖共转运蛋白 2 抑制剂治疗有或无心力衰竭心血管死亡或住院的关系。
Eur J Heart Fail. 2021 Jun;23(6):1026-1036. doi: 10.1002/ejhf.2073. Epub 2020 Dec 29.
10
Sotagliflozin in Patients with Diabetes and Recent Worsening Heart Failure.索格列净治疗伴有近期恶化心力衰竭的糖尿病患者。
N Engl J Med. 2021 Jan 14;384(2):117-128. doi: 10.1056/NEJMoa2030183. Epub 2020 Nov 16.